Professor Inna Gaidukova of the Northwestern State Medical University and Associate Professor Svetlana Lapshina of the Kazan State Medical University presented data showing that the new drug seniprutug showed a significant superiority over placebo from the first week of use. The effect continued to increase until the end of the study, opening new horizons in the treatment of ankylosing spondylitis.

The APLAR Congress is the largest event in the field of rheumatology, bringing together leading experts to share experience and new methods in the treatment of musculoskeletal diseases.

Source: Ferra

Previous articleA scientist explained whether we can produce energy using volcanoes. Science and technology August 23, 2024 12:45.
Next articleT-Bank will launch its own online service for the sale of goods in Russia August 23, 2024, 13:17
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.

LEAVE A REPLY

Please enter your comment!
Please enter your name here